Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Krabeva 100 mg Solution for Infusion:
Krabeva 100 mg Solution for Infusion is an anticancer medication used in the treatment of various types of cancer, including colon and rectal cancer, non-small cell lung cancer, kidney cancer, brain cancer, ovarian cancer, and cervical cancer. It works by preventing the growth of new blood vessels that feed cancerous tumors and inhibits the proliferation of tumors.
Krabeva 100 mg Solution for Infusion is an effective first-line treatment option when used in combination with other cancer medications. It is administered as an infusion, typically through a small needle in a vein or through a port placed under the skin. Your doctor will determine the appropriate dosage and duration of treatment, monitoring you for any signs of infusion reactions such as high blood pressure and difficulty breathing. Treatment with Krabeva 100 mg Solution for Infusion continues as long as the disease is controlled and side effects are manageable, with your doctor deciding whether you should discontinue treatment. Monitoring of blood pressure and urine protein levels may be advised during treatment with this medication.
Uses of Krabeva 100 mg Solution for Infusion:
Krabeva 100 mg Solution for Infusion is indicated for the treatment of the following conditions:
Colon and rectal cancer
Non-small cell lung cancer
Kidney cancer
Brain cancer
Ovarian cancer
Cervical cancer
Benefits of Krabeva 100 mg Solution for Infusion:
In Colon and Rectal Cancer:
Krabeva 100 mg Solution for Infusion treats colon and rectal cancer by reducing the risk of further tumor growth and spread. It inhibits the growth of cancer cells and prevents their proliferation.
In Non-small Cell Lung Cancer:
Krabeva 100 mg Solution for Infusion helps treat non-small cell lung cancer, either alone or in combination with other medications. It is a potent and highly toxic medication, and the risks and benefits should be discussed with your physician.
In Kidney Cancer:
Krabeva 100 mg Solution for Infusion is used to treat kidney cancer and associated symptoms such as blood in the urine, unexplained back pain or weight loss, fatigue, and loss of appetite. It halts cancer growth and prevents the proliferation of cancer cells.
In Brain Cancer:
Krabeva 100 mg Solution for Infusion inhibits the growth and proliferation of cancer cells in brain cancer, helping to control the disease. Any concerns should be discussed with your physician.
In Ovarian Cancer:
Krabeva 100 mg Solution for Infusion is effective in treating ovarian cancer by inhibiting the growth and proliferation of cancer cells. However, it may cause some side effects, which should be discussed with your physician.
In Cervical Cancer:
Krabeva 100 mg Solution for Infusion is an anticancer medication used to eliminate malignant cells in cervical cancer, a cancer that develops in the cervix of females.
Mechanism of Action of Krabeva 100 mg Solution for Infusion:
Krabeva 100 mg Solution for Infusion is an anti-angiogenic medication that works by blocking a protein called vascular endothelial growth factor (VEGF). This prevents the formation of blood vessels that supply oxygen and nutrients to cancerous cells, thereby inhibiting tumor growth and proliferation.